Jung Im Lee

US Patent:

6562847, May 13, 2003

Filed:

Aug 25, 1999

Appl. No.:

09/383142

Inventors:

Jung S. Lee - Ambler PA

Assignee:

Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ

International Classification:

H01N 4340

US Classification:

514343, 5462764, 5462681, 546194, 5462784

Abstract:

The present invention provides compounds of the formula: wherein m is 0, 1 or 2; p is 0 or 1; Y is O, S, S(O) or S(O) and R to R are various substituents as selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimers disease, memory loss or dementia or loss of motor function.

US Patent:

6771688, Aug 3, 2004

Filed:

Sep 19, 2000

Appl. No.:

09/664646

Inventors:

Jung Ah Lee - Pittstown NJ
Steven Andrew Wood - Hotwells, GB
Gregory J Wroclawski - Kinnelon NJ
Woodson Dale Wynn - Basking Ridge NJ

Assignee:

Lucent Technologies Inc. - Murray Hill NJ

International Classification:

H04L 2730

US Classification:

375142, 375143, 375150, 375152, 375343

Abstract:

Known sequences are detected and identified in a fast fading environment using a segmented correlator and FHT (Fast Hadamard Transform) architecture. The incoming sequence of samples or data is segmented into blocks. Each block is individually detected using a correlator/FHT segment. Each sequence identifying output of each correlator/FHT segment is summed with the corresponding output of other correlator/FHT segments. Each sum is compared with a threshold to determine whether a particular sequence has been detected and identified.

US Patent:

6888001, May 3, 2005

Filed:

Apr 2, 2003

Appl. No.:

10/405250

Inventors:

Jung S. Lee - Ambler PA, US

International Classification:

H01N043/40
C07D401/00

US Classification:

546276, 546268, 546194, 546278, 514343

Abstract:

The present invention provides compounds of the formula: wherein m is 0, 1 or 2; p is 0 or 1; Y is O, S, S(O) or S(O)and Rto Rare various substituents as selective modulators of the nicotinic acetylcholine receptor useful in the treatment of pain, Alzheimer's disease, memory loss or dementia or loss of motor function.

US Patent:

6907091, Jun 14, 2005

Filed:

Jan 31, 2001

Appl. No.:

09/773176

Inventors:

Jung Ah Lee - Pittstown NJ, US

Assignee:

Lucent Technologies Inc. - Murray Hill NJ

International Classification:

H04L027/06
H04B007/216

US Classification:

375343, 375150

Abstract:

Detection and identification of known sequences such as sequences composed of Walsh-Hadamard sequence and scrambling sequence are provided in a fast fading and frequency offset environment using a segmented correlator and FHT (Fast Hadamard Transform) architecture with frequency offset compensation. The incoming sequence of samples or data is segmented into blocks. Each block is individually detected using a correlator/FHT segment. Each sequence identifying output of each correlator/FHT segment is multiplied by a sinusoid for frequency offset compensation. The frequency offset compensated output from each correlator/FHT segment is summed with the corresponding frequency offset compensated output of other correlator/FHT segments. Each sum is compared with a threshold to determine whether a particular sequence has been detected and identified.

US Patent:

6958349, Oct 25, 2005

Filed:

Mar 31, 2003

Appl. No.:

10/403186

Inventors:

John R. Carson - Norristown PA, US
Michele C. Jetter - Norristown PA, US
Jung S. Lee - Ambler PA, US
Mark A. Youngman - Warminster PA, US

Assignee:

Ortho-McNeil Pharmaceuticals, Inc. - Raritan NJ

International Classification:

A61K031/47
C07D215/12
C07D215/16

US Classification:

514314, 546174, 546175, 546177

Abstract:

This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.

US Patent:

7321645, Jan 22, 2008

Filed:

Aug 29, 2003

Appl. No.:

10/651200

Inventors:

Jung Ah Lee - Pittstown NJ, US
Anil M. Rao - Randolph NJ, US

Assignee:

Lucent Technologies Inc. - Murray Hill NJ

International Classification:

H03D 1/00
H04L 27/06

US Classification:

375343, 375134, 375136, 375137, 375142, 375145, 375147, 375150

Abstract:

In a method and arrangement for detecting a random access channel preamble in a received uplink signal, the uplink signal is received at one or more receive antennas and contains data related to a random access channel preamble. The received uplink signal is subjected to spatial processing and temporal processing in order to detect the random access channel preamble. A best cell portion for communicating with a user may also be determined based on the detected preamble. The best cell portion represents a portion of a cell where a received uplink signal from a user has a highest signal to interference ratio. The detected random access channel preamble is indicative of the best cell portion for communicating with the user.

US Patent:

7358261, Apr 15, 2008

Filed:

Dec 16, 2004

Appl. No.:

11/014471

Inventors:

John R. Carson - Norristown PA, US
Michele C. Jetter - Norristown PA, US
Jung S. Lee - Ambler PA, US
Mark A. Youngman - Warminster PA, US

Assignee:

Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ

International Classification:

A61K 31/47
C07D 215/38

US Classification:

514311, 514312, 514314, 546153, 546176, 546178

Abstract:

This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.

US Patent:

7435822, Oct 14, 2008

Filed:

Feb 2, 2005

Appl. No.:

11/048976

Inventors:

John R. Carson - Norristown PA, US
Jung S. Lee - McLean VA, US

Assignee:

Janssen Pharmaceutica N.V. - Beerse

International Classification:

C07D 401/00
C07D 405/00
C07D 409/00
C07D 411/00
C07D 413/00

US Classification:

546125

Abstract:

This invention is directed to 3-(diheteroarylmethylene)-8-azabicyclo[3. 2. 1] octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3. 2. 1] octane derivatives useful as δ-opioid, μ-opioid, or δ-opioid and μ-opioid receptor receptor modulators. Depending on their agonist or antagonist effect, the compounds are useful analgesics, immunosuppressants, antiinflammatory agents, agents for the treatment of neurological and psychiatric conditions, medicaments for drug and alcohol abuse, agents for treating gastritis and diarrhea, cardiovascular agents and agents for the treatment of respiratory diseases.